ARTICLE | Company News
Bio-Matrix Scientific gene/cell therapy news
May 14, 2012 7:00 AM UTC
Bio-Matrix said it established subsidiary Regen BioPharma Inc. to develop stem cell therapies. Regen also secured $20 million in financing from Southridge Partners and identified three core technologi...